Optipres

📋 Product Overview Table

🧬 What is Optipres Eye Drop (Betaxolol)?

Optipres Eye Drop, produced by Cipla Limited, is a beta-1 selective adrenergic receptor blocker formulated for ophthalmic use. It’s primarily used to treat open-angle glaucoma and ocular hypertension (OHT) by lowering elevated intraocular pressure (IOP), which is a major risk factor for optic nerve damage and vision loss.

The active ingredient Betaxolol works by reducing the production of aqueous humor within the eye. Compared to non-selective beta-blockers, Betaxolol poses fewer risks for patients with respiratory issues like asthma or COPD, making it a safer alternative for long-term glaucoma management.

This clear, sterile solution is typically applied twice daily and is suitable for both newly diagnosed patients and those requiring adjunctive therapy with other IOP-lowering medications.

🎬 Educational Video Placeholder

🩺 Doctor’s Expert Commentary

Dr. Reema Thakur, Ophthalmologist:
“Optipres is an excellent choice for patients with contraindications to non-selective beta blockers. Its cardioselectivity ensures fewer systemic side effects, while maintaining IOP control effectively.”

💉 Dosage & Administration

Do not touch the dropper tip to any surface. Remove contact lenses before applying.

⚠️ Side Effects, Warnings & Storage

• Common Side Effects: Eye irritation, blurred vision, foreign body sensation
• Less Common Risks: Bradycardia, fatigue, shortness of breath (rare)
• Precautions: Not recommended in sinus bradycardia or AV block patients
• Storage: Store below 25°C, do not freeze, keep tightly closed after use

🌍 Global Availability

🔗 Related Indian Alternatives (Same Therapeutic Category)

📚 Trusted Medical References

• Drugs.com – Betaxolol Ophthalmic
• NHS – Glaucoma Treatment
• Cipla Limited Official Site

⚠️ Medical Disclaimer
This article is for informational use only. Consult your ophthalmologist before initiating any treatment.